Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial
article
OA: closed
CC0
⤵ 49 in-corpus citations
AI-generated summary
This double-blind, randomized, placebo-controlled trial assessed the impact of gonadotropin-releasing hormone agonist therapy on endometriosis-associated pain and quality of life during the stimulatory phase.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveThe purpose of this study was a quantification of changes in endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy.Study designOne hundred twenty women with significant endometriosis-associated pain participated in a 1-month double-blind, randomized, placebo-controlled trial. Pain was measured at baseline and at 2 and 4 weeks with visual analog scales and the Endometriosis Symptom Severity score. Quality of life was measured with the SF-36 instrument. Group means and SEMs were calculated. Paired t tests were used after determination of data normality.ResultsCompared with placebo-treated control subjects women treated with gonadotropin-releasing hormone agonist had a statistically (P <. 0001) and clinically significant temporary increase in pain and a concomitant decrease in quality of life.ConclusionThe stimulatory phase of gonadotropin-releasing hormone agonist therapy is associated with an increase in endometriosis-associated pain and a decrease in quality of life.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (15)
- Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
- Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis via openalex
- Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex
- Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group. via openalex
- W2023953074 via openalex
- W2043018121 via openalex
- W2077563872 via openalex
- W2399999566 via openalex
- W2412382222 via openalex
- W2414317794 via openalex
- W2477008945 via openalex
- W6600951853 via openalex
- W73242332 via openalex
- W88607751 via openalex
- W1993331455 via openalex
Cited by (49)
- Safety of current strategies to manage moderate to severe pain in patients with endometriosis 2025
- A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action 2024
- Gonadotropin-releasing hormone analogues for endometriosis 2023
- A review of phase II and III drugs for the treatment and management of endometriosis 2023
- GnRH Agonists and Antagonists in Endometriosis and Adenomyosis Therapy 2022
- Advances in targeting estrogen synthesis and receptors in patients with endometriosis 2022
- Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients 2021
- The role of acupuncture in the treatment of women with pain in endometriosis 2021
- Evaluation of the SF‑36 questionnaire for assessment of the quality of life of endometriosis patients undergoing treatment: A systematic review and meta‑analysis 2021
- Additional file 1 of Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients 2021
- Additional file 1 of Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients 2021
- Use of GnRH analogue in the endometriosis recurrence after surgery 2020
- Tolerability considerations for gonadotropin-releasing hormone analogues for endometriosis 2020
- Systematic review of quality of life measures in patients with endometriosis 2019
- A comprehensive review of hormonal and biological therapies for endometriosis: latest developments 2019
- Current and emerging treatment options for endometriosis 2018
- Effect of neuromuscular electrical stimulation for endometriosis-associated pain 2018
- Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal. RPC Endométriose CNGOF-HAS 2018
- Current and Emerging Therapeutics for the Management of Endometriosis 2018
- Effects of acupuncture for the treatment of endometriosis-related pain: A systematic review and meta-analysis 2017
- Pain Catastrophizing and Pain Health-Related Quality-of-Life in Endometriosis 2017
- Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal et perspectives thérapeutiques 2017
- Treatment of pain associated with deep endometriosis: alternatives and evidence 2015
- Emerging treatment of endometriosis 2015
- Evaluation of endometriosis-associated pain and influence of conventional treatment: a systematic review 2015
- Validação da Versão Portuguesa do Questionário EHP-30 (The Endometriosis Health Profile-30) 2015
- Systematic review of endometriosis pain assessment: how to choose a scale? 2014
- Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases 2014
- Validation of the SF-36 in patients with endometriosis 2013
- Quality of life in patients with endometriosis and the effect of pertubation with lidocaine – a randomized controlled trial 2013
- Health-related quality of life in women with endometriosis: a systematic review 2012
- Ectopic uterine tissue as a chronic pain generator 2012
- Current pharmacotherapy for endometriosis 2010
- An investigation of the surgical treatment of endometriosis 2010
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 2010
- A longitudinal 2-year follow-up of quality of life in women referred for colposcopy after an abnormal cervical smear 2009
- Measuring quality of life in chronic pelvic pain syndrome 2009
- Noninvasive assessment of ectopic uterine tissue development in rats using magnetic resonance imaging 2007
- Are gonadotropin-releasing hormone analogs and laparoscopic ablation equally effective treatments for endometriosis? 2007
- Health-related quality of life burden of women with endometriosis: a literature review 2006
- GnRH agonist and antagonist: Options for endometriosis pain treatment 2006
- Quality of life after laparoscopic colorectal resection for endometriosis 2006
- GnRH analogs: Options for endometriosis-associated pain treatment 2006
- Advances in the management of endometriosis: an update for clinicians 2005
- Laparoscopic excision of endometriosis: A randomized, placebo-controlled trial 2004
- Quality of life instruments in studies of chronic pelvic pain: a systematic review 2004
- Gonadotropin Releasing Honnone Agonist and Antagonist for Endometriosis 2003
- Development of an Endometriosis Quality-of-Life Instrument 2001
- Leuprorelin lowers QOL initially in endometriosis 2000
Source provenance
- europepmc
- last seen: 2026-08-11T06:11:44.160905+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:13:36.046895+00:00
License: CC0
· commercial use OK